Skip to main content
5 April 2026
Last updated:
Saturday 4 April 2026
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Transgene in vanguard of oncolytic virus therapy
Read more
A new business model for Pharma
Read more
US Special Protocol Assessments for Oncology
Read more
European biotechs start to look undervalued
Read more
An interview with Thomas Lönngren -- Managing change at the EMA
Read more
JAK2 inhibitors: a breakthrough in oncology?
Read more
European Commission lifts funding for innovation
Read more
Boehringer Ingelheim opts for nimble approach
Read more
Affimed brings new antibody to the clinic
Read more
$2 billion in new US funding
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
76
Page
77
Page
78
Page
79
Current page
80
Page
81
Page
82
Page
83
Page
84
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
